Literature DB >> 27891533

Screening for Cancer in Persons Living with HIV Infection.

James J Goedert1, H Dean Hosgood2, Robert J Biggar3, Howard D Strickler2, Charles S Rabkin1.   

Abstract

Survival with human immunodeficiency virus (HIV) infection has greatly improved due to effective antiretroviral therapy (ART). As infectious complications have declined, malignancy now accounts for over one-third of deaths among people living with HIV (PLWH). Based on practices in the general population, cancer screening of PLWH can decrease both morbidity and mortality. In this article, we review and consider directed approaches for colorectal, breast, cervical and lung cancer screening. Furthermore, routine physical examinations may detect lymphomas and skin, anal and oral cancers. Comprehensive cancer prevention in PLWH should also include ART adherence, vaccination against oncogenic viruses, treatment of hepatitis viruses and smoking cessation. Cancer screening for PLWH warrants further research on safety and efficacy as well as targeted efforts to increase adherence.

Entities:  

Mesh:

Year:  2016        PMID: 27891533      PMCID: PMC5120729          DOI: 10.1016/j.trecan.2016.06.007

Source DB:  PubMed          Journal:  Trends Cancer        ISSN: 2405-8025


  85 in total

1.  Risk of cervical precancer and cancer among HIV-infected women with normal cervical cytology and no evidence of oncogenic HPV infection.

Authors:  Marla J Keller; Robert D Burk; Xianhong Xie; Kathryn Anastos; L Stewart Massad; Howard Minkoff; Xiaonan Xue; Gypsyamber D'Souza; D Heather Watts; Alexandra M Levine; Philip E Castle; Christine Colie; Joel M Palefsky; Howard D Strickler
Journal:  JAMA       Date:  2012-07-25       Impact factor: 56.272

2.  Effectiveness of AFP and ultrasound tests on hepatocellular carcinoma mortality in HCV-infected patients in the USA.

Authors:  Hashem B El-Serag; Jennifer R Kramer; G John Chen; Zhigang Duan; Peter A Richardson; Jessica A Davila
Journal:  Gut       Date:  2011-01-21       Impact factor: 23.059

3.  Increased risk of histologically defined cancer subtypes in human immunodeficiency virus-infected individuals: clues for possible immunosuppression-related or infectious etiology.

Authors:  Meredith S Shiels; Eric A Engels
Journal:  Cancer       Date:  2012-02-22       Impact factor: 6.860

4.  Incidence of HIV-related anal cancer remains increased despite long-term combined antiretroviral treatment: results from the french hospital database on HIV.

Authors:  Christophe Piketty; Hana Selinger-Leneman; Anne-Marie Bouvier; Aurelien Belot; Murielle Mary-Krause; Claudine Duvivier; Manuela Bonmarchand; Laurent Abramowitz; Dominique Costagliola; Sophie Grabar
Journal:  J Clin Oncol       Date:  2012-10-22       Impact factor: 44.544

Review 5.  Human papillomavirus type distribution in anal cancer and anal intraepithelial lesions.

Authors:  Brooke E Hoots; Joel M Palefsky; Jeanne M Pimenta; Jennifer S Smith
Journal:  Int J Cancer       Date:  2009-05-15       Impact factor: 7.396

6.  Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.

Authors:  Jacques Ferlay; Isabelle Soerjomataram; Rajesh Dikshit; Sultan Eser; Colin Mathers; Marise Rebelo; Donald Maxwell Parkin; David Forman; Freddie Bray
Journal:  Int J Cancer       Date:  2014-10-09       Impact factor: 7.396

Review 7.  Screening guidelines for non-AIDS defining cancers in HIV-infected individuals.

Authors:  Deepthi Mani; David M Aboulafia
Journal:  Curr Opin Oncol       Date:  2013-09       Impact factor: 3.645

8.  Prospective stage-stratified approach to AIDS-related Kaposi's sarcoma.

Authors:  Mark Bower; Alessia Dalla Pria; Chris Coyle; Eileen Andrews; Victoria Tittle; Sharanjit Dhoot; Mark Nelson
Journal:  J Clin Oncol       Date:  2013-12-30       Impact factor: 44.544

9.  Human papillomavirus antibodies and future risk of anogenital cancer: a nested case-control study in the European prospective investigation into cancer and nutrition study.

Authors:  Aimée R Kreimer; Paul Brennan; Krystle A Lang Kuhs; Tim Waterboer; Gary Clifford; Silvia Franceschi; Angelika Michel; Martina Willhauck-Fleckenstein; Elio Riboli; Xavier Castellsagué; Allan Hildesheim; Renée Turzanski Fortner; Rudolf Kaaks; Domenico Palli; Ingrid Ljuslinder; Salvatore Panico; Françoise Clavel-Chapelon; Marie-Christine Boutron-Ruault; Sylvie Mesrine; Antonia Trichopoulou; Pagona Lagiou; Dimitrios Trichopoulos; Petra H Peeters; Amanda J Cross; H Bas Bueno-de-Mesquita; Paolo Vineis; Nerea Larrañaga; Valeria Pala; María-José Sánchez; Carmen Navarro; Aurelio Barricarte; Rosario Tumino; Kay-Tee Khaw; Nicholas Wareham; Heiner Boeing; Annika Steffen; Ruth C Travis; J Ramón Quirós; Elisabete Weiderpass; Michael Pawlita; Mattias Johansson
Journal:  J Clin Oncol       Date:  2015-02-09       Impact factor: 44.544

10.  Cancer screening test use - United States, 2013.

Authors:  Susan A Sabatino; Mary C White; Trevor D Thompson; Carrie N Klabunde
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2015-05-08       Impact factor: 17.586

View more
  8 in total

1.  Healthy behavioral choices and cancer screening in persons living with HIV/AIDS are different by sex and years since HIV diagnosis.

Authors:  Akemi T Wijayabahu; Zhi Zhou; Robert L Cook; Babette Brumback; Nicole Ennis; Lusine Yaghjyan
Journal:  Cancer Causes Control       Date:  2019-02-09       Impact factor: 2.506

2.  Opportunities to Understand Unique Cancer Risks in Global HIV-Infected Populations.

Authors:  Marie-Josèphe Horner; Satish Gopal
Journal:  J Natl Cancer Inst       Date:  2018-09-01       Impact factor: 13.506

Review 3.  HIV/AIDS Associated Lymphoma: Review.

Authors:  Ayenew Berhan; Biruk Bayleyegn; Zegeye Getaneh
Journal:  Blood Lymphat Cancer       Date:  2022-04-29

4.  Anal cancer screening among women with HIV: provider experiences and system-level challenges.

Authors:  Robin T Higashi; Serena A Rodriguez; Andrea C Betts; Jasmin A Tiro; Amneris E Luque; Rachel Rivera; Arti Barnes
Journal:  AIDS Care       Date:  2021-02-17

5.  Cause-specific mortality after diagnosis of cancer among HIV-positive patients: A collaborative analysis of cohort studies.

Authors:  Adam Trickey; Margaret T May; M John Gill; Sophie Grabar; Janne Vehreschild; Ferdinand W N M Wit; Fabrice Bonnet; Matthias Cavassini; Sophie Abgrall; Juan Berenguer; Christoph Wyen; Peter Reiss; Katharina Grabmeier-Pfistershammer; Jodie L Guest; Leah Shepherd; Ramon Teira; Antonella d'Arminio Monforte; Julia Del Amo; Amy Justice; Dominique Costagliola; Jonathan A C Sterne
Journal:  Int J Cancer       Date:  2020-03-12       Impact factor: 7.396

Review 6.  HPV Self-Sampling for Cervical Cancer Screening among Women Living with HIV in Low- and Middle-Income Countries: What Do We Know and What Can Be Done?

Authors:  Matthew Asare; Elakeche Abah; Dorcas Obiri-Yeboah; Lisa Lowenstein; Beth Lanning
Journal:  Healthcare (Basel)       Date:  2022-07-08

Review 7.  A Framework for Cervical Cancer Elimination in Low-and-Middle-Income Countries: A Scoping Review and Roadmap for Interventions and Research Priorities.

Authors:  Michelle B Shin; Gui Liu; Nelly Mugo; Patricia J Garcia; Darcy W Rao; Cara J Bayer; Linda O Eckert; Leeya F Pinder; Judith N Wasserheit; Ruanne V Barnabas
Journal:  Front Public Health       Date:  2021-07-01

Review 8.  Lung Cancer (LC) in HIV Positive Patients: Pathogenic Features and Implications for Treatment.

Authors:  Stefano Frega; Alessandra Ferro; Laura Bonanno; Valentina Guarneri; PierFranco Conte; Giulia Pasello
Journal:  Int J Mol Sci       Date:  2020-02-26       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.